Sitagliptin hydrochloride monohydrateProduct ingredient for Sitagliptin
- Name
- Sitagliptin hydrochloride monohydrate
- Drug Entry
- Sitagliptin
Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitusLabel,4,1,2. The effect of this medication leads to glucose dependent increases in insulin and decreases in glucagon to improve control of blood sugarLabel,1. Sitagliptin was granted FDA approval on October 16, 20066.
- Accession Number
- DBSALT003498
- Synonyms
- 1-BUTANONE, 3-AMINO-1-(5,6-DIHYDRO-3-(TRIFLUOROMETHYL)-1,2,4-TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)-4-(2,4,5-TRIFLUOROPHENYL)-, HYDROCHLORIDE, HYDRATE (1:1:1), (3R)- / 1,2,4-TRIAZOLO(4,3-A)PYRAZINE, 7-((3R)-3-AMINO-1-OXO-4-(2,4,5-TRIFLUOROPHENYL)BUTYL)-5,6,7,8-TETRAHYDRO-3-(TRIFLUOROMETHYL)-, MONOHYDROCHLORIDE, MONOHYDRATE / SITAGLIPTIN MONOHYDROCHLORIDE MONOHYDRATE